Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
OS Therapies Inc has a consensus price target of $18.75 based on the ratings of 4 analysts. The high is $21 issued by EF Hutton on October 3, 2024. The low is $15 issued by Maxim Group on January 16, 2025. The 3 most-recent analyst ratings were released by D. Boral Capital on May 15, 2025, April 22, 2025, and April 7, 2025, respectively. With an average price target of $20 between D. Boral Capital, there's an implied 1069.59% upside for OS Therapies Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/15/2025 | Buy Now | 1069.59% | D. Boral Capital | Jason Kolbert42% | $20 → $20 | Maintains | Buy | Get Alert |
04/22/2025 | Buy Now | 1069.59% | D. Boral Capital | Jason Kolbert42% | $20 → $20 | Maintains | Buy | Get Alert |
04/07/2025 | Buy Now | 1069.59% | D. Boral Capital | Jason Kolbert42% | $20 → $20 | Maintains | Buy | Get Alert |
04/02/2025 | Buy Now | 1011.11% | Lake Street | Chad Messer34% | → $19 | Initiates | → Buy | Get Alert |
03/31/2025 | Buy Now | 1069.59% | D. Boral Capital | Jason Kolbert42% | $20 → $20 | Maintains | Buy | Get Alert |
02/24/2025 | Buy Now | 1069.59% | D. Boral Capital | Jason Kolbert42% | $20 → $20 | Maintains | Buy | Get Alert |
02/20/2025 | Buy Now | 1069.59% | D. Boral Capital | Jason Kolbert42% | $20 → $20 | Maintains | Buy | Get Alert |
02/04/2025 | Buy Now | 1069.59% | D. Boral Capital | Jason Kolbert42% | $20 → $20 | Maintains | Buy | Get Alert |
01/30/2025 | Buy Now | 1069.59% | D. Boral Capital | Jason Kolbert42% | $20 → $20 | Maintains | Buy | Get Alert |
01/16/2025 | Buy Now | 777.19% | Maxim Group | Jason McCarthy42% | $8 → $15 | Maintains | Buy | Get Alert |
01/15/2025 | Buy Now | 1069.59% | D. Boral Capital | Jason Kolbert42% | $20 → $20 | Maintains | Buy | Get Alert |
11/26/2024 | Buy Now | 367.84% | Maxim Group | Jason McCarthy42% | → $8 | Initiates | → Buy | Get Alert |
10/03/2024 | Buy Now | 1128.07% | EF Hutton | Jason Kolbert42% | $21 → $21 | Maintains | Buy | Get Alert |
09/16/2024 | Buy Now | 1128.07% | EF Hutton | Jason Kolbert42% | $21 → $21 | Maintains | Buy | Get Alert |
09/03/2024 | Buy Now | 1128.07% | EF Hutton | Jason Kolbert42% | → $21 | Initiates | → Buy | Get Alert |
The latest price target for OS Therapies (AMEX:OSTX) was reported by D. Boral Capital on May 15, 2025. The analyst firm set a price target for $20.00 expecting OSTX to rise to within 12 months (a possible 1119.51% upside). 15 analyst firms have reported ratings in the last year.
The latest analyst rating for OS Therapies (AMEX:OSTX) was provided by D. Boral Capital, and OS Therapies maintained their buy rating.
There is no last upgrade for OS Therapies
There is no last downgrade for OS Therapies.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OS Therapies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OS Therapies was filed on May 15, 2025 so you should expect the next rating to be made available sometime around May 15, 2026.
While ratings are subjective and will change, the latest OS Therapies (OSTX) rating was a maintained with a price target of $20.00 to $20.00. The current price OS Therapies (OSTX) is trading at is $1.64, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.